{"name":"Rovi Pharmaceuticals Laboratories","slug":"rovi-pharmaceuticals-laboratories","ticker":"","exchange":"","domain":"rovilaboratories.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Clexane","genericName":"Clexane","slug":"clexane","indication":"Other","status":"marketed"},{"name":"ISM®","genericName":"ISM®","slug":"ism","indication":"Other","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Placebo of Risperidone ISM","genericName":"Placebo of Risperidone ISM","slug":"placebo-of-risperidone-ism","indication":"Control arm in Phase 3 trials for schizophrenia or other psychotic disorders (specific indication depends on the active Risperidone ISM trial)","status":"phase_3"}]}],"pipeline":[{"name":"Clexane","genericName":"Clexane","slug":"clexane","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ISM®","genericName":"ISM®","slug":"ism","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Placebo of Risperidone ISM","genericName":"Placebo of Risperidone ISM","slug":"placebo-of-risperidone-ism","phase":"phase_3","mechanism":"This is a placebo control formulation used in clinical trials to compare against the active Risperidone ISM (intramuscular sustained-release) antipsychotic.","indications":["Control arm in Phase 3 trials for schizophrenia or other psychotic disorders (specific indication depends on the active Risperidone ISM trial)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxPWmR1RlE4MlM3bjhwejhVZUNEdUtNbzZndXZUYXlQRmR6eEpwbWFWTTM3NWlVS0N5UmFaOUtPYUNQWHhhaXYxWXNaNWNxMFh4OTE5aUFfVkg0QVpYc1oyWnZvTkx1U3lwb1F4QTdvRGR6UFJWNHJNS2JQU2F4MHJiNlI4YlRpbHZ2amFiMWVlNWdjVDN1Y2lvZ0QtT0xOM0xUSnRCc1JLaHlGSlBzVzBValZXN0pOS2I1ZmhTUDRCcU9KU3N2clZtd3BIbl93MUpNaU1XMDJfTGIxU3lXZ3pQak5QNHBYS2I4TldRbnpJTUF4WFM1SDI5NzNaazVLdzMtQWhOYWRnWkRSV3I4TFE?oc=5","date":"2026-04-07","type":"pipeline","source":"The Corner .eu","summary":"Rovi completes acquisition of pharmaceutical manufacturing plant in Phoenix, Arizona, following execution of agreement with Bristol Myers Squibb - The Corner .eu","headline":"Rovi completes acquisition of pharmaceutical manufacturing plant in Phoenix, Arizona, following execution of agreement w","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxQZGZhUldiU3piWjBKcmRIOW9HbUtuUGJkdXJ6RmhtaDFEOTZHY2RQaDM2Y2hmSDcyRGZCWkgwSGN0RDIxYm0xTVRjMUVVX2cxTVdsRTQ0X1lGRGhha2k2Q0xHOFdPRFFxSm5zVnc1SnpPRmFDVUtrUFBhcHBTSE5HWlV1Vm5wMnpiY0swVDhsZjRIUzU0WXJjemRiUzJ6bUFnTVk3YXVhdWRsX01PM0d3dkE5aEdrX3NCTmFHeU43TnpIbEpFT09iejdadHY1ZnJ4d1ZpMnJjRXJ1NHh1U0ZmdkFDcHVyVFNXelRiVG9BVkRjOG9Qdzkya2JvMk9sWGFndFdXMlNncXhWSHJDTUFNUGN1OWZFZ1pYazBlVUd1QzJzWDJOWGFZOUhmWlNrVnJjbG9kRE9UOXhWalMz?oc=5","date":"2026-03-11","type":"pipeline","source":"PR Newswire","summary":"Bipolar Depression Market Expected to Witness Accelerated Expansion During the Forecast Period (2026-2036) Amid Advancements in Psychiatric Therapies | DelveInsight - PR Newswire","headline":"Bipolar Depression Market Expected to Witness Accelerated Expansion During the Forecast Period (2026-2036) Amid Advancem","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPVVp6Tks2c0JUbE5HcktfNXMyTVZDUWdBOUFFd3VRYlF5ZWN5enhaZWpTSWd4NlZna2U0WnhJMXBobVF6alMyVXRvcUd3d1lCSDlueVl3TGl2Slhub3VGM1lvcjFWZDdIZVF5NnZIaHJFVmc4b25ETlRUMldBRklZdHlRaDJqQVVKT0pGWV81dHo0VllCeUtHT3VCSmdWMkhkcl82TUNkLVpmSVczV1k0Zm9zLXlYRHRFLUdj?oc=5","date":"2026-02-17","type":"pipeline","source":"European Pharmaceutical Review","summary":"Rois appoints Kimberlee Steele as Chief Commercial Officer - European Pharmaceutical Review","headline":"Rois appoints Kimberlee Steele as Chief Commercial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOMzVYWXRSbjBTLXdNUmptbUpDSzYwVUdIOU5NLWJDYk5GcGwyb2tuSFhMRUdoLUF2OXRka0Vhb0UyM3k4cU1Td0JOZEx1UUxFNzBoNlA4SXVnV2VJc21jS18wRmZPY1BmR1h3TEdCVUtmdmQ4MlZDbnZQeDlZZjlTQmVHaTV4NW5ySHpaZHpFNXlDbVBmMDRnbGJuOA?oc=5","date":"2025-10-21","type":"pipeline","source":"La Moncloa","summary":"The President of the Government of Spain meets with Roche CEO to discuss the upcoming investments in Spain and the current state of the pharmaceutical sector - La Moncloa","headline":"The President of the Government of Spain meets with Roche CEO to discuss the upcoming investments in Spain and the curre","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQYUxoWmpBN1I2bmdMajludHVGVm53Tld4aFBqM3VhU0VlRE1zbWJRNE81VjQzbEt1OUVVbWI0b2Y1OWgxQ2JHS1NwSEZ3WlJJcDVSMGFyVXBFcWxDd1lrNUFlV0lIM2hQRlB6THpmRF83NVZoR0EyME9SbkxOeGRnSzZFSDJpcVpMbWRGWTZYNnFxNFozZ0ZMbG16WDZ3STdTTEpBM1BwUUdnTTVybnpwQldQOHYtWnA0T3JtRXZWTUVfRUk?oc=5","date":"2025-10-13","type":"deal","source":"European Pharmaceutical Review","summary":"Rovi’s injectables CDMO rebrands as Rois and acquires BMS facility - European Pharmaceutical Review","headline":"Rovi’s injectables CDMO rebrands as Rois and acquires BMS facility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOdkF4QjY1M1l3ci1pV09zU2tKVmZnOGNBdTk0ZGROMEpJd1BhZTlUMlhDLWJaWEJXX0dWdFZBV2h4aHdhX2lGT3ljalR3ZEZ2NEdFcnVvcHBwUU56blQ5NkEzbE85elV1T29FVklqeHBsT3JOdWFsSGpJVE9JSzVkVlNZNHpOaXZZcHZ1QlVQUE05Y19OSWNZWW9DeFhKUDVWTkdfbHd1d056Zw?oc=5","date":"2025-09-30","type":"deal","source":"Fierce Pharma","summary":"Rovi acquires BMS facility in Phoenix and strikes $250M manufacturing deal - Fierce Pharma","headline":"Rovi acquires BMS facility in Phoenix and strikes $250M manufacturing deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOVWtKLVVfY2VNdHRnVGNoX3JGTWlWemdBcDJIWS1OWExmQXEyV1VueWhXMkJmQkFJME9tUXhpYUhETFdyMVFZYU5veWN4cjlQZ2F5SWVsQVZ5a29oZlNhNVg3ZkU3ZmFKdFlsN2xSbm9ObHB2U2RfYW9ET0ktQjRTVlp3UkpCVzlqQ0lreElZZXR2eE1uT3dNRXh2YlZTVTc2dzRzanVkSWZSMk1DQzRNTGtR?oc=5","date":"2024-10-24","type":"pipeline","source":"Reuters","summary":"Spanish drugmaker Rovi to keep third-party manufacturing business - Reuters","headline":"Spanish drugmaker Rovi to keep third-party manufacturing business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxNTGJDaWxXY05HbFdIT0ZyeXhGUElYZ21PVkdaMnYtWWtQTGxSeDNJenlUc0hwNzlzQWZQVmUxaHg0S2FnN0VpRFY4MzZJa1JkbERwdVBFenM3V2NweVljcThycTFJSnBGLTU1dElueHE2alZwZ2M2cEhEcFRrbFQzdkpMTG5wS2VVTmN3Tnd1UDgyNEZkWE9QLWtJeS05dmpJeF9MR3hWMG5hRmt2aWc5Z29nWXE3Q2tzYlh5X19oLVBOTEQ2XzhfUDZ6SmZGUTNoZUR0SEdCWE1TWFFGdTgtUmc2LVFoTVJVTUIyRU5JM1pHaV9KSGN5OVcyYUg1dw?oc=5","date":"2024-08-26","type":"regulatory","source":"PR Newswire","summary":"Schizophrenia Market: RISVAN's Approval Has Sparked a Competitive Race Among Pharmaceutical Companies | DelveInsight - PR Newswire","headline":"Schizophrenia Market: RISVAN's Approval Has Sparked a Competitive Race Among Pharmaceutical Companies | DelveInsight","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQRXpRNWV2bC15TGJ4YzNQbmpHSEwyMlB5YmZtbVhRN1F2S3Bjem5XWUVhM2g5T0hvMnFDVFd3RWJDQkpuc0s2bHZyTFdIQWd0bFRiTUlTRDlPcHRuY2RuODBqd2w3WUE1Y3VaTDNiaTJEeElVU25qdHk4dXljc3NDdkFYNEU5ZVdwRkl4MGRPTndpUGdocVJya01vRy1naHI2UjdUOFh4Z214bVE?oc=5","date":"2024-06-27","type":"pipeline","source":"Fierce Pharma","summary":"Spain's Rovi receives offers for potential sale of €2B-plus CDMO group - Fierce Pharma","headline":"Spain's Rovi receives offers for potential sale of €2B-plus CDMO group","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNQi1aMEg4UV9rNk1iWGtvdThXdWJmb3VmN3o2UzBmXzA0T1dqMEJKWG1yZDhxZzJFbnBPcEIzdktfY1Y0d25kdmRtYWF2a0xyYU4yc01XQW5iVUdzM3BXTk10MFJ6UTljRXNwaVVyMUJzXzJTQ292RXFZaGoteTlOb0RtVG8wRENHZ194RWUyS29KTGdmclBxUXpidGg3WE9fMjhFbWJhZENmZURMS05fTkVmemRJdmdfWHp6R3VWZXBpdy02?oc=5","date":"2024-03-07","type":"pipeline","source":"Reuters","summary":"Rovi explores sale of unit that makes drugs for third parties - Reuters","headline":"Rovi explores sale of unit that makes drugs for third parties","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOUndqajh3RDBURENmS2dUaXVVRk1UdERlTDJFTTNCeVd2dEhXV0ZqdzVfMjFISlZpTEdMVzNLNDF2ZHRJS1B1Yi1MNDJoTlBJbXR2c29EbUZfMWF3Q3VmT3IwSzA2OGl0eFNDZVc2bm80UFliWllhcEVLYVFhNTJqcGlydllwTFp0Zjh1UlJaakVtZlpsd2FpcUN2QVVVTEtqY0RJLU04OFFaemk0LS14Y2hqY2NPcG5CWk1YWGt6dWFDV184WHd1N25KdTBJdEVpZ0E?oc=5","date":"2022-02-16","type":"deal","source":"Reuters","summary":"Rovi seals 10-year Moderna deal extension to manufacture mRNA drugs - Reuters","headline":"Rovi seals 10-year Moderna deal extension to manufacture mRNA drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPN1Bfc3o1Y0xDcmEySVE1TmJGdzdCYzBYaVZXUnJKUmxMSmNoQlUtNFJnaW9GNjZSbGhEeUw0WkdhU1N6eHFldkNJSi1IclV4R2NremdTaV92cXE3SXV5NC1pZ2lZMlA0ZjNvUV9BbERWZXpZZEo5Zk5nejRBam1MMHA5bmFKcGprSzhwT3B4TnNzYmtnOEdXRU5kcjgtRWxqeW40azJHbGZnVFJLZUJtSFdXTEh4RUVibjdRTU5vUC0?oc=5","date":"2021-10-01","type":"pipeline","source":"Fierce Pharma","summary":"Moderna report says 'human error' to blame for contamination found in 3 vaccine lots from Rovi plant - Fierce Pharma","headline":"Moderna report says 'human error' to blame for contamination found in 3 vaccine lots from Rovi plant","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"marketed":2,"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}